Summary
CJC-1295 and Selank are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: CJC-1295 is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas Selank is more often associated with the realm of Neurology and brain health and Immunology and inflammation. They also influence different molecular systems, with CJC-1295 tracking more closely to Growth hormone axis while Selank centers more on GPCR receptor. Both are synthetic in origin with CJC-1295 in Preclinical development and Selank approved for Research use only. CJC-1295 takes the form of a peptide conjugate, whereas Selank is closer to a linear peptide, CJC-1295 incorporates d-amino acid substitution features that are not part of Selank; while their sequence patterns also diverge, with CJC-1295 showing alpha-helical domain features and Selank showing proline-rich features.